NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders

Zonghui Ma; Jia Zhou

doi:10.1021/acs.jmedchem.5c01818

NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders

Zonghui Ma
, Jia Zhou

Pharmacology & Toxicology

Research output: Contribution to journal › Editorial › peer-review

23 Scopus citations

Original language	English (US)
Pages (from-to)	14129-14136
Number of pages	8
Journal	Journal of medicinal chemistry
Volume	68
Issue number	14
DOIs	https://doi.org/10.1021/acs.jmedchem.5c01818
State	Published - Jul 24 2025

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.5c01818

Cite this

@article{a3c7457c183c43a189c66455a1d5ed47,

title = "NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders",

author = "Zonghui Ma and Jia Zhou",

year = "2025",

month = jul,

day = "24",

doi = "10.1021/acs.jmedchem.5c01818",

language = "English (US)",

volume = "68",

pages = "14129--14136",

journal = "Journal of medicinal chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "14",

}

TY - JOUR

T1 - NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA

T2 - The Beginning of a New Era of PROTAC Degraders

AU - Ma, Zonghui

AU - Zhou, Jia

PY - 2025/7/24

Y1 - 2025/7/24

UR - https://www.scopus.com/pages/publications/105012467561

UR - https://www.scopus.com/pages/publications/105012467561#tab=citedBy

U2 - 10.1021/acs.jmedchem.5c01818

DO - 10.1021/acs.jmedchem.5c01818

M3 - Editorial

C2 - 40702893

AN - SCOPUS:105012467561

SN - 0022-2623

VL - 68

SP - 14129

EP - 14136

JO - Journal of medicinal chemistry

JF - Journal of medicinal chemistry

IS - 14

ER -

NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this